These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23633687)

  • 21. Better late than never: time to up-schedule hydrocodone combination products.
    Kolodny A
    Pain Med; 2013 Nov; 14(11):1627-8. PubMed ID: 24238352
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent issues regarding controlled substances.
    Helgeland D
    S D Med; 2013 Mar; 66(3):105, 107. PubMed ID: 23544298
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of the Hydrocodone Schedule Change on Opioid Prescription Patterns in South Dakota.
    Kuschel LM; Mort JM
    S D Med; 2017 Oct; 70(10):449-455. PubMed ID: 28957619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine.
    Bonnie RJ; Kesselheim AS; Clark DJ
    JAMA; 2017 Aug; 318(5):423-424. PubMed ID: 28715551
    [No Abstract]   [Full Text] [Related]  

  • 25. Wake up call from the Northeastern District Dental Society: initiative concerning drug-seeking activity.
    Wainio JD; Huneke AR; Hedin GJ
    Northwest Dent; 2010; 89(6):29-31. PubMed ID: 21287814
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA bans sale of unapproved cough suppressants containing hydrocodone.
    Mitka M
    JAMA; 2007 Nov; 298(19):2251-2. PubMed ID: 18029822
    [No Abstract]   [Full Text] [Related]  

  • 27. The downside of upscheduling.
    Gudin J; Lee AJ
    Pain Med; 2013 Nov; 14(11):1628-9. PubMed ID: 24238353
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA actions to prevent prescription drug abuse.
    Jeske AH
    Tex Dent J; 2005 Jul; 122(7):634-45. PubMed ID: 16152888
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management.
    Singla A; Sloan P
    J Opioid Manag; 2013; 9(1):71-80. PubMed ID: 23709306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balancing pain control with misuse and abuse.
    TDIC Risk Management Staff
    J Calif Dent Assoc; 2014 Oct; 42(10):721-4. PubMed ID: 25345118
    [No Abstract]   [Full Text] [Related]  

  • 31. Canadian approval sought for controversial pain drug.
    Brown C
    CMAJ; 2014 May; 186(8):571. PubMed ID: 24664646
    [No Abstract]   [Full Text] [Related]  

  • 32. Trends in opioid analgesic abuse and mortality in the United States.
    Dart RC; Surratt HL; Cicero TJ; Parrino MW; Severtson SG; Bucher-Bartelson B; Green JL
    N Engl J Med; 2015 Jan; 372(3):241-8. PubMed ID: 25587948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools?
    Meltzer EC; Hall WD; Fins JJ
    Pain Med; 2013 Jul; 14(7):982-7. PubMed ID: 23594383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. US bill would force FDA to withdraw approval of new pain drug Zohydro.
    McCarthy M
    BMJ; 2014 Mar; 348():g2195. PubMed ID: 24637611
    [No Abstract]   [Full Text] [Related]  

  • 35. Using Prescription Drug Monitoring Programs to Address Drug Abuse.
    Hansen M
    NCSL Legisbrief; 2015 Mar; 23(12):1-2. PubMed ID: 26173300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescription for passing inspection.
    Rossi MS
    N Y State Dent J; 2007; 73(4):6-7. PubMed ID: 17891874
    [No Abstract]   [Full Text] [Related]  

  • 37. Rehabilitating opioid regulation: a prescription for the FDA's next proposal of an opioid risk evaluation and mitigation strategy (REMS).
    Homenko H
    Health Matrix Clevel; 2012; 22(1):273-313. PubMed ID: 22616548
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug diversion administrative revocation and application hearings for medical and pharmacy practitioners: a primer for navigating murky, drug-infested waters.
    Mulrooney JJ; Hull AJ
    Albany Law Rev; 2014-2015; 78(2):101-64. PubMed ID: 25330551
    [No Abstract]   [Full Text] [Related]  

  • 39. Controlled Substances Quotas. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2018 Jul; 83(136):32784-90. PubMed ID: 30020581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.
    Hall PB
    W V Med J; 2014; 110(6):6-10. PubMed ID: 25651658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.